CCM
INSM icon

Coldstream Capital Management’s Insmed INSM Stock Holding History

Coldstream Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$611K Sell
3,737
-111
-3% -$17.1K 0.01% 646
2025
Q4 		$670K Sell
3,848
-672
-15% -$123K 0.01% 594
2025
Q3 		$651K Sell
4,520
-455
-9% -$55.7K 0.01% 624
2025
Q2 		$501K Buy
4,975
+244
+5% +$18.7K 0.01% 654
2025
Q1 		$361K Buy
4,731
+1,180
+33% +$90.3K 0.01% 749
2024
Q4 		$245K Buy
3,551
+61
+2% +$4.39K 0.01% 927
2024
Q3 		$255K Buy
+3,490
New +$258K 0.01% 922

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Coldstream Capital Management's INSM Position: Q1 2026 in Review

Coldstream Capital Management reduced its Insmed (INSM) stake by 2.9% in Q1 2026, selling an estimated $17.1K and leaving 3,737 shares worth $611K. The position accounts for 0.01% of the portfolio, ranked #646.

Coldstream Capital Management first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. The position peaked at $670K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Coldstream Capital Management held 3,737 shares of Insmed worth $611K as of Q1 2026.
  • Coldstream Capital Management sold 111 Insmed shares in Q1 2026, an estimated $17.1K.
  • Insmed made up 0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #646 holding.
  • Coldstream Capital Management first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • Coldstream Capital Management's Insmed position peaked at $670K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.